Alcon Inc. (LON:0A0D)
London · Delayed Price · Currency is GBP · Price in CHF 62.41
+0.56 (0.91%)
At close: Jan 30, 2026
Alcon Market Cap
Alcon has a market cap or net worth of 28.99 billion as of January 30, 2026. Its market cap has decreased by -13.68% in one year.
Market Cap
28.99B
Enterprise Value
31.81B
Revenue
7.58B
Ranking
n/a
PE Ratio
37.22
Stock Price
62.41
Market Cap Chart
Since April 9, 2019, Alcon's market cap has increased from 21.72B to 28.99B, an increase of 33.45%. That is a compound annual growth rate of 4.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 28.99B | -0.66% |
| Dec 30, 2025 | 29.18B | -12.92% |
| Dec 30, 2024 | 33.51B | 11.02% |
| Dec 29, 2023 | 30.18B | 8.25% |
| Dec 30, 2022 | 27.88B | -13.06% |
| Dec 30, 2021 | 32.07B | 31.94% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 210.92B |
| GSK plc | 75.29B |
| Haleon | 33.75B |
| Smith & Nephew | 10.55B |
| Convatec Group | 4.48B |
| Hikma Pharmaceuticals | 3.39B |
| Genus | 2.11B |
| HUTCHMED (China) | 1.89B |